BDNF tagging polymorphisms and haplotype analysis in sporadic Parkinson's disease in diverse ethnic groups

Neurosci Lett. 2007 Mar 19;415(1):59-63. doi: 10.1016/j.neulet.2006.12.038. Epub 2006 Dec 30.

Abstract

Experimental and clinical data suggest that genetic variations in brain-derived neurotrophic factor (BDNF) gene may affect risk for Parkinson's disease (PD). We performed a case-control association analysis of BDNF in three independent Caucasian cohorts (Greek, North American, and Finnish) of PD using eight tagging SNPs and five constructed haplotypes. No statistically significant differences in genotype and allele frequencies were found between cases and controls in all series. A relatively rare BDNF haplotype showed a trend towards association in the Greek (p=0.02) and the Finnish (p=0.03) series (this haplotype was not detected in the North American series). However, given the large number of comparisons these associations are considered non-significant. In conclusion, our results do not provide statistically significant evidence that common genetic variability in BDNF would associate with the risk for PD in the Caucasian populations studied here.

MeSH terms

  • Aged
  • Brain / metabolism
  • Brain / physiopathology
  • Brain Chemistry / genetics
  • Brain-Derived Neurotrophic Factor / genetics*
  • Cohort Studies
  • DNA Mutational Analysis
  • Female
  • Finland / epidemiology
  • Gene Frequency
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease / genetics*
  • Genetic Testing
  • Genetic Variation / genetics
  • Genotype
  • Greece / epidemiology
  • Haplotypes / genetics*
  • Humans
  • Male
  • Middle Aged
  • North America / epidemiology
  • Parkinson Disease / ethnology*
  • Parkinson Disease / genetics*
  • Parkinson Disease / metabolism
  • Polymorphism, Genetic / genetics*
  • White People / genetics

Substances

  • Brain-Derived Neurotrophic Factor
  • Genetic Markers